葛兰素史克再爆丑闻：中国区前主管婚外性爱视频遭群发

    或许有些人真的是间谍电影看多了。

    周末，导致英国最大的制药公司葛兰素史克（GlaxoSmithKline Plc）出现震荡的行贿丑闻出现扑朔迷离的转折：一段记录了葛兰素史克中国区业务主管马克锐与其中国籍女友性爱过程的视频录像发到了这家公司高管的手中，而且其中也许包含着某种勒索企图。这段视频似乎是在马克锐位于上海的公寓中用隐秘摄像头拍摄的。

    据《泰晤士报》（The Times of）报道，这段视频录像以电子邮件附件的形式发给了葛兰素史克的13位高管，其中包括公司的首席执行官安伟杰爵士，发件人在邮件中控诉葛兰素史克公司通过贿赂的手段让中国医生以高价采购药品和医疗产品。

    周一，葛兰素史克公司的一位发言人证实了性爱录像视频的存在，但拒绝透露更多的细节。马克锐与他妻子现在已处于分居状态。

    据报道，这段录像视频是在2013年4月发送的。当时，中国政府部门刚刚针对这家公司地区业务涉嫌腐败的问题启动了一项大规模的调查。此后的调查导致马克锐和葛兰素史克另外两位公司主管被捕，同时遭到拘捕的还有私人调查员韩飞龙。据称，葛兰素史克曾经雇佣此人来调查视频的幕后黑手。调查提出的指控最高可判处无期徒刑。

    针对葛兰素史克的行贿调查震动了很多在华经营的公司，很多人认为要进入这个快速增长的关键市场，除了遵照要求行贿外别无他法。透明国际组织（Transparency International）去年曾经对世界各国的腐败感知度进行过调查，在上榜的177个国家中，中国排在第80位。20国集团（G20）成员国中只有五个国家排在中国后面。中国政府宣称已经挖出了一个从公司高管到医生和其他医疗系统官员的“完整贿赂链条”，《金融时报》（the Financial Times）援引一位政府经济犯罪调查官员的话说，“葛兰素史克（中国）投资公司在中国的所有部门和制药生产子公司全都（涉嫌）卷入了”这起贿赂案。

    与此同时，英国严重欺诈办公室（Serious Fraud Office）也对葛兰素史克展开了独立调查。这家公司在伊拉克和波兰同样面临腐败指控。

    葛兰素史克周一表示：“这些指控让我们深感担忧。我们已经投入大量资源来调查这起事件，同时还成立了独立法律审查团，希望查明在中国发生的一切。我们还将继续对公司在中国的业务进行彻底整改。”

    葛兰素史克还表示，公司“从此事中汲取了深刻的教训”，同时“决心采取一切必要的行动”。（财富中文网）

    译者：徐黄兆

    You might be forgiven that someone has been watching too many spy movies.

    The scandal that has rocked the U.K.’s biggest drug company, GlaxoSmithKline Plc GSK -0.56% took a bizarre turn at the weekend after it emerged that a video recording of Mark Reilly, GSK’s head of Chinese operations, having sex with his Chinese girlfriend, was sent to top company executives in what appears to be an attempt at blackmail. The incident appeared to have been filmed in Reilly’s Shanghai’s flat using a covert camera.

    The Times of London reported that the tape was sent to 13 senior staff, including chief executive Sir Andrew Witty, as an attachment to an e-mail that alleged the company was bribing doctors in China to pay for drugs and healthcare products at inflated prices.

    A spokesman for GSK Monday confirmed the existence of the tape but declined to give any further details. Reilly is separated from his wife.

    The tapes were reportedly sent in April 2013, just before Chinese authorities launched a wide-ranging probe into suspected corruption at the company’s local operations. That probe has since led to the arrest of Reilly and two other GSK executives, as well as that of Peter Humphrey, a private investigator whom GSK reportedly hired to find out the source of the video. The charges carry a maximum sentence of life imprisonment.

    The investigation has sent shockwaves through many companies operating in China, where many feel they have no option but to comply with demands for bribes to get access to a key growth market. China ranked 80th out of 177 countries in Transparency International’s last survey of corruption perceptions around the world. Only five of co-members of the G20 score worse.

    Chinese officials claim to have established “a complete chain of bribery” from the company’s top management to doctors and other healthcare officials, and the Financial Times reported an official in the government’s economic crime investigation as saying that “all departments and pharmaceutical production subsidiaries of GSK (China) Investment across China were fully engaged” in the alleged bribery.

    The UK’s Serious Fraud Office, meanwhile, haslaunched its own investigation into GSK, which has also faced claims of corruption in Iraq and Poland.

    GSK said Monday that “the allegations that have been raised are deeply concerning to us. We have committed significant resources to find out what happened in China, including an independent legal review. We also continue to make fundamental changes to our business in China.”

    It said it was “learning lessons from this situation” and “determined to take all actions necessary as a result.”